Literature DB >> 27529364

Glass Forming Ability of Amorphous Drugs Investigated by Continuous Cooling and Isothermal Transformation.

Lasse I Blaabjerg1,2, Eleanor Lindenberg2, Korbinian Löbmann1, Holger Grohganz1, Thomas Rades1.   

Abstract

The aim of this study was to investigate the glass forming ability of 12 different drugs by the determination of continuous cooling and isothermal transformation diagrams in order to elucidate if an inherent differentiation between the drugs with respect to their the glass forming ability can be made. Continuous-cooling-transformation (CCT) and time-temperature-transformation (TTT) diagrams of the drugs were developed in order to predict the critical cooling rate necessary to convert the drug from the melt into an amorphous form. While TTT diagrams overestimated the actual critical cooling rate, they allowed an inherent differentiation of glass forming ability for the investigated drugs into drugs that are extremely difficult to amorphize (>750 °C/min), drugs that require modest cooling rates (>10 °C/min), and drugs that can be made amorphous even at very slow cooling rates (>2 °C/min). Thus, the glass forming ability can be predicted by the use of TTT diagrams. In contrast to TTT diagrams, CCT diagrams may not be suitable for small organic molecules due to poor separation of exothermic events, which makes it difficult to determine the zone of recrystallization. In conclusion, this study shows that glass forming ability of drugs can be predicted by TTT diagrams.

Keywords:  CCT diagram; TTT diagram; amorphous; classification; critical cooling rate

Mesh:

Substances:

Year:  2016        PMID: 27529364     DOI: 10.1021/acs.molpharmaceut.6b00650

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state.

Authors:  Sneha Rathi; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

2.  Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).

Authors:  Zhiqing Hu; Pengchong Xu; Eman A Ashour; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2022-06-17       Impact factor: 3.246

Review 3.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

4.  Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties.

Authors:  Khadijah Edueng; Christel A S Bergström; Johan Gråsjö; Denny Mahlin
Journal:  Pharmaceutics       Date:  2019-08-21       Impact factor: 6.321

5.  Myth or Truth: The Glass Forming Ability Class III Drugs Will Always Form Single-Phase Homogenous Amorphous Solid Dispersion Formulations.

Authors:  Piyush Panini; Massimiliano Rampazzo; Abhishek Singh; Filip Vanhoutte; Guy Van den Mooter
Journal:  Pharmaceutics       Date:  2019-10-14       Impact factor: 6.321

Review 6.  Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions.

Authors:  Kohsaku Kawakami
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.